Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity
The coronavirus infectious disease 2019 (COVID-19) pandemic has hit the world, affecting health, medical care, economies and our society as a whole. Furthermore, COVID-19 pandemic joins the increasing prevalence of metabolic syndrome in western countries. Patients suffering from obesity, type II dia...
Main Authors: | Patricia Lamadrid, Marta Alonso-Peña, David San Segundo, Mayte Arias-Loste, Javier Crespo, Marcos Lopez-Hoyos |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.651728/full |
Similar Items
-
Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
by: Francesca Fianchi, et al.
Published: (2021-06-01) -
Innate and Adaptive Immune Assessment at Admission to Predict Clinical Outcome in COVID-19 Patients
by: David San Segundo, et al.
Published: (2021-07-01) -
The interplay between non-alcoholic fatty liver disease and innate immunity in hepatitis B virus patients
by: Fayed Attia Koutb Megahed, et al.
Published: (2021-03-01) -
Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update
by: Ilaria Barchetta, et al.
Published: (2020-10-01) -
The Crosstalk between Hypoxia and Innate Immunity in the Development of Obesity-Related Nonalcoholic Fatty Liver Disease
by: María Teresa Arias-Loste, et al.
Published: (2015-01-01)